Infinity Pharma Treatment for Lung Cancer Misses Study Goals

Posted On 26 Sep 2013
By :

The biopharmaceutical drug developer said it won’t initiate any new studies of the treatment–retaspimycin hydrochloride–to treat patients with non-small cell lung cancer who have a history of smoking.

http://t.co/V0QaTo6SFx #lcsm

Read the source article at online.wsj.com

About the Author

Leave a Reply